The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10
Open accessAbstract
Dyskeratosis congenita (DC) is characterized by multiple features including mucocutaneous abnormalities, bone marrow failure and an increased predisposition to cancer. It exhibits marked clinical and genetic heterogeneity. DKC1 encoding dyskerin, a component of H/ACA small nucleolar ribonucleoprotein (snoRNP) particles is mutated in X-linked recessive DC. Telomerase RNA component (TERC), the RNA component and TERT the enzymatic component of telomerase, are mutated in autosomal dominant DC, suggesting that DC is primarily a disease of defective telomere maintenance. The gene(s) involved in autosomal recessive DC remains elusive. This paper describes studies aimed at defining the genetic basis of AR-DC. Homozygosity mapping in 16 consanguineous families with 25 affected individuals demonstrates that there is no single genetic locus for AR-DC. However, we show that NOP10, a component of H/ACA snoRNP complexes including telomerase is mutated in a large consanguineous family with classical DC. Affected homozygous individuals have significant telomere shortening and reduced TERC levels. While a reduction of TERC levels is not a universal feature of DC, it can be brought about through a reduction of NOP10 transcripts, as demonstrated by siRNA interference studies. A similar reduction in TERC levels is also seen when the mutant NOP10 is expressed in HeLa cells. These findings identify the genetic basis of one subtype of AR-DC being due to the first documented mutations in NOP10. This further strengthens the model that defective telomere maintenance is the primary pathology in DC and substantiates the evidence in humans for the involvement of NOP10 in the telomerase complex and telomere maintenance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autosomal dominant forms are caused by mutations in TERT, TERC or the telomere binding protein TRF1-interacting nuclear factor 2 (156-159).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [159]
In the citing paper
“Eight mutant genes have been identified in dyskeratosis congenita9,38,39,60–64, and all of them encode telomerase or telomere protein components (summarized in Table 1).”
From The telomere syndromes (2012) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple sequence alignment with hierarchical clustering.
Corpet, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.22.10881 · Cited by 5,575
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Gabert, J. A., Beillard, E. J., van der Velden, V. H. J., Bi, W., Grimwade, D. J., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J., Cavé, H., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403135 · Cited by 1,534
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Bunce, M., O'Neill, C. M., Barnardo, M., Krausa, P., Browning, M. J., Morris, P. J., & Welsh, K. I. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb03127.x · Cited by 994
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976
Self-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Self-citationBeillard, E. J., Pallisgaard, N., van der Velden, V. H. J., Bi, W., Dee, R., van der Schoot, C. E., Delabesse, É., Macintyre, E. A., Gottardi, E. M., Saglio, G. N., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403136 · Cited by 887
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
Jones, A. V. (2005) · Blood · doi:10.1182/blood-2005-03-1320 · Cited by 843 · cited 1×
“Samples were genotyped using a tetra-primer sequence-specific assay, a method that uses two primer pairs to specifically amplify the normal and mutant sequences plus a positive control in a single reaction (36) using sequence-specific primer PCR methodology (SSP– PCR) (37).”
MethodKiss (2002) · doi:10.1016/s0092-8674(02)00718-3 · Cited by 816
Flagged first, then by citations
1 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 316
Dyskeratosis congenita: The first NIH clinical research workshop
Savage, S. A., Dokal, I. S., Armanios, M. Y., Aubert, G., Cowen, E. W., Domingo, D. L., Giri, N., Greene, M. H., Orchard, P. J., Tolar, J., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22061 · Cited by 69
Self-citationTrahan, C., Martel, C., & Dragon, F. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp551 · Cited by 73
Giri, N., Lee, R. L., Faro, A., Huddleston, C. B., White, F. V., Alter, B. P., & Savage, S. A. (2011) · BMC Blood Disorders · doi:10.1186/1471-2326-11-3 · Cited by 70
Tsangaris, E., Klaassen, R. J., Fernandez, C. V., Yanofsky, R., Shereck, E. B., Champagne, J., Silva, M., Lipton, J. H., Brossard, J., Michon, B., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2011.089821 · Cited by 68
Ribosome biogenesis and function in development and disease
Ni, C., & Buszczak, M. (2023) · Development · doi:10.1242/dev.201187 · Cited by 67
Neutropenia and Primary Immunodeficiency Diseases
Rezaei, N., Moazzami, K., Aghamohammadi, A., & Klein, C. (2009) · International Reviews of Immunology · doi:10.1080/08830180902995645 · Cited by 68
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of TelomeresPreprint
Roake, C. M., & Artandi, S. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026088 · Cited by 70
Telomere Biology and Telomere Diseases: Implications for Practice and Research
Young, N. S. (2010) · Hematology · doi:10.1182/asheducation-2010.1.30 · Cited by 66
TIN2 Protein Dyskeratosis Congenita Missense Mutants Are Defective in Association with Telomerase
Yang, D., He, Q., Kim, H., Ma, W., & Songyang, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225870 · Cited by 66
The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres
Frank, A. K., Tran, D. C., Qu, R. W., Stohr, B. A., Segal, D. J., & Xu, L. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005410 · Cited by 67
Venturi, G., & Montanaro, L. (2020) · Cells · doi:10.3390/cells9102300 · Cited by 62
Ribosomal dysfunction and inherited marrow failure
Ganapathi, K. A., & Shimamura, A. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07095.x · Cited by 65
The shelterin complex and hematopoiesis
Jones, M., Bisht, K. K., Savage, S. A., Nandakumar, J., Keegan, C. E., & Maillard, I. P. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84547 · Cited by 64
TOE1 acts as a 3′ exonuclease for telomerase RNA and regulates telomere maintenance
Deng, T., Huang, Y. Y., Weng, K., Song, L., Li, Y., Shi, G. W., Chen, Y., Huang, J., Liu, D., Ma, W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1019 · Cited by 60
Du, H.-Y., Pumbo, E., Manley, P. E., Field, J. J., Bayliss, S. J., Wilson, D. B., Mason, P. J., & Bessler, M. (2007) · Blood · doi:10.1182/blood-2007-10-120907 · Cited by 60
Substrate RNA positioning in the archaeal H/ACA ribonucleoprotein complex
Liang, B., Xue, S., Terns, R. M., Terns, M. P., & Li, H. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1336 · Cited by 59
Cui, C., Liu, Y., Gerloff, D., Rohde, C., Pauli, C., Köhn, M., Misiak, D., Oellerich, T., Schwartz, S., Schmidt, L., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01570-y · Cited by 60
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in micePreprint
Frescas, D., & de Lange, T. (2014) · Genes & Development · doi:10.1101/gad.233395.113 · Cited by 61
Telomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 63
The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells
Fong, Y. W., Ho, J. J., Inouye, C. J., & Tjian, R. (2014) · eLife · doi:10.7554/elife.03573 · Cited by 54
Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
Relitti, N., Saraswati, A. P., Federico, S., Khan, T., Brindisi, M., Zisterer, D. M., Brogi, S., Gemma, S., Butini, S., & Campiani, G. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200102104930 · Cited by 55
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita
Goldman, F. D., Aubert, G., Klingelhutz, A. J., Hills, M., Cooper, S., Hamilton, W. S., Schlueter, A. J., Lambie, K., Eaves, C. J., & Lansdorp, P. M. (2008) · Blood · doi:10.1182/blood-2007-10-120204 · Cited by 54
Balogh, E., Chandler, J. C., Varga, M., Tahoun, M. M., Menyhárd, D. K., Schay, G., Goncalves, T., Hamar, R., Légrádi, R., Szekeres, Á., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002328117 · Cited by 53
Genetic Interstitial Lung Disease
Devine, M., & Garcia, C. K. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.11.001 · Cited by 55
Alawi, F., & Lin, P. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20715 · Cited by 51
Amir, M., Κhan, P., Queen, A., Dohare, R., Alajmi, M. F., Hussain, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020) · Cells · doi:10.3390/cells9020359 · Cited by 53
Maturation of small nucleolar RNAs: from production to function
Webster, S. F., & Ghalei, H. (2023) · RNA Biology · doi:10.1080/15476286.2023.2254540 · Cited by 47
Telomere Dysfunction, Chromosomal Instability and Cancer
Meena, J. K., Rudolph, K. L., & Güneş, Ç. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_3 · Cited by 51
Telomerase RNA processing: Implications for human health and disease
Nagpal, N., & Agarwal, S. (2020) · Stem Cells · doi:10.1002/stem.3270 · Cited by 47
Hepatic manifestations of telomere biology disorders
Patnaik, M. M., Kamath, P. S., & Simonetto, D. A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.006 · Cited by 45
Non-canonical roles of canonical telomere binding proteins in cancers
Akıncılar, S. C., Chan, C. H. T., Ng, Q. F., Fidan, K., & Tergaonkar, V. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03783-0 · Cited by 45
Lamm, N., Elly, O., Shponkin, R., Richler, C., Aker, M., & Tzfati, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005666 · Cited by 46
Telomere biology and translational research
Mason, P. J., & Perdigones, N. (2013) · Translational research · doi:10.1016/j.trsl.2013.08.009 · Cited by 44
The wide-ranging clinical implications of the Short Telomere Syndromes
Barbaro, P. M., Ziegler, D. S., & Reddel, R. R. (2016) · Internal Medicine Journal · doi:10.1111/imj.12868 · Cited by 40
Hills, M., & Lansdorp, P. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04565.x · Cited by 42
Fok, W. C., Shukla, S., Vessoni, A. T., Brenner, K. A., Parker, R., Sturgeon, C. M., & Batista, L. F. Z. (2019) · Blood · doi:10.1182/blood-2018-11-885368 · Cited by 40
Recent progress in dyskeratosis congenita
Nishio, N., & Kojima, S. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0695-5 · Cited by 40
Bergstrand, S., Böhm, S., Malmgren, H., Norberg, A., Sundin, M., Nordgren, A., & Farnebo, M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2421-4 · Cited by 37
Dyskeratosis congenita and the DNA damage response
Kirwan, M., Beswick, R. W., Walne, A. J., Hossain, U., Casimir, C. M., Vulliamy, T., & Dokal, I. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08679.x · Cited by 37
Self-citationKirwan, M., Beswick, R. W., Vulliamy, T., Nathwani, A. C., Walne, A. J., Casimir, C. M., & Dokal, I. S. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07516.x · Cited by 39
Self-citationKoo, B., Park, C., Fernandez, C. F., Chim, N., Ding, Y., Chanfreau, G., & Feigon, J. F. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.06.022 · Cited by 46
Dey, A., & Chakrabarti, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020333 · Cited by 40
Irvine, A. D., & Mellerio, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch15 · Cited by 35
Plant telomere biology: The green solution to the end-replication problem
Shakirov, E. V., Chen, J. J. ‐., & Shippen, D. E. (2022) · The Plant Cell · doi:10.1093/plcell/koac122 · Cited by 40
Understanding telomere diseases through analysis of patient-derived iPS cells
Batista, L. F. Z., & Artandi, S. E. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.07.006 · Cited by 35
H/ACA Small Ribonucleoproteins: Structural and Functional Comparison Between Archaea and Eukaryotes
Czekay, D. P., & Kothe, U. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.654370 · Cited by 36
Ataxia and pancytopenia caused by a mutation in TINF2
Tsangaris, E., Adams, S., Yoon, G., Chitayat, D. A., Lansdorp, P. M., Dokal, I. S., & Dror, Y. (2008) · Human Genetics · doi:10.1007/s00439-008-0576-7 · Cited by 32
Self-citationInherited bone marrow failure syndromes in 2012
Sakaguchi, H., Nakanishi, K., & Kojima, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1249-9 · Cited by 32
Control of protein synthesis through mRNA pseudouridylation by dyskerin
Pederiva, C., Trevisan, D. M., Peirasmaki, D., Chen, S., Savage, S. A., Larsson, O. S., Ule, J., Baranello, L., Agostini, F., & Farnebo, M. (2023) · Science Advances · doi:10.1126/sciadv.adg1805 · Cited by 32
Dyskerin, telomerase and the DNA damage response
Gu, B.-W., Bessler, M., & Mason, P. J. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7265 · Cited by 31
First heterozygousNOP10mutation in familial pulmonary fibrosis
Kannengiesser, C., Manali, E. D., Revy, P., Callebaut, I., Ba, I., Borgel, A., Oudin, C., Haritou, A., Kolilekas, L., Malagari, K. S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02465-2019 · Cited by 30
Telomere dysfunction in human diseases: the long and short of it!
Carroll, K. A., & Ly, H. (2009) · Europe PMC (PubMed Central) · Cited by 30
Do ribosomopathies explain some cases of common variable immunodeficiency?
Khan, S., Pereira, J., Darbyshire, P. J., Holding, S., Doré, P. C., Sewell, W. A. C., & Huissoon, A. P. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04280.x · Cited by 30
Brault, M. E., Lauzon, C., & Autexier, C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt204 · Cited by 28
Zeng, X., Thumati, N. R., Fleisig, H. B., Hukezalie, K. R., Savage, S. A., Giri, N., Alter, B. P., & Wong, J. M. Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr504 · Cited by 28
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC
Laudadio, I., Orso, F., Azzalin, G., Calabrò, C., Berardinelli, F., Coluzzi, E., Gioiosa, S., Taverna, D., Sgura, A., Carissimi, C., et al. (2018) · EMBO Reports · doi:10.15252/embr.201845969 · Cited by 26
Telomerase and telomere biology in hematological diseases: A new therapeutic target
Allegra, A., Innao, V., Penna, G., Gerace, D. G., Allegra, A. G., & Musolino, C. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.02.002 · Cited by 31
Richard, M. A., Lupo, P. J., Morton, L. M., Yasui, Y., Sapkota, Y., Arnold, M., Aubert, G., Neglia, J. P., Turcotte, L. M., Leisenring, W. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228887 · Cited by 28
Long-distance placement of substrate RNA by H/ACA proteins
Liang, B., Kahen, E., Calvin, K., Zhou, J., Blanco, M. R., & Li, H. (2008) · RNA · doi:10.1261/rna.1109808 · Cited by 26
Hoareau‐Aveilla, C., Henry, Y. A. L., & Leblanc, T. M. (2008) · médecine/sciences · doi:10.1051/medsci/2008244390 · Cited by 32
Novel variants in Nordic patients referred for genetic testing of telomere-related disorders
Norberg, A., Rosén, A., Raaschou‐Jensen, K., Kjeldsen, L., Moilanen, J. S., Paulsson-Karlsson, Y., Baliakas, P., Lohi, O., Ahmed, A. B., Kittang, A. O., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0112-8 · Cited by 26
Regulation of human telomerase RNA biogenesis and localization
Jian, Q., & Autexier, C. (2020) · RNA Biology · doi:10.1080/15476286.2020.1809196 · Cited by 27
Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report
Ratnasamy, V., Suganthan, N., Sirisena, N. D., Grüning, N., Brandau, O., Kumanan, T., Dagnall, C. L., McReynolds, L. J., Savage, S. A., & Dissanayake, V. H. W. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0584-y · Cited by 27
Vieri, M., Brümmendorf, T. H., & Beier, F. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101282 · Cited by 23
Sleiman, S., Marshall, A. E., Dong, X., Mhanni, A. A., Alidou-D’Anjou, I., Frosk, P., Marin, S. E., Stark, Z., Bigio, M. R. D., McBride, A., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab247 · Cited by 24
Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita
Callea, M., Martinelli, D., Cammarata-Scalisi, F., Grimaldi, C., Jilani, H., Grimaldi, P., Willoughby, C. E., & Morabito, A. (2022) · Genes · doi:10.3390/genes13030496 · Cited by 25
Ueda, Y., Calado, R. T., Norberg, A., Kajigaya, S., Roos, G., Hellström‐Lindberg, E., & Young, N. S. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-68 · Cited by 24
Dysfunctional telomeres and hematological disorders
Fiorini, E., Santoni, A., & Colla, S. (2018) · Differentiation · doi:10.1016/j.diff.2018.01.001 · Cited by 25
Abdulkina, L. R., Kobayashi, C., Lovell, J. T., Chastukhina, I. B., Aklilu, B. B., Agabekian, I. A., Suescún, A. V., Valeeva, L. R., Nyamsuren, C., Aglyamova, G. V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13448-z · Cited by 27
Vasianovich, Y., Bajon, E., & Wellinger, R. J. (2020) · eLife · doi:10.7554/elife.60000 · Cited by 17
Telomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 22
Han, X., Yu, Y. L., Ma, D., Zhang, Z. Y., & Liu, X. H. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1864630 · Cited by 22
Yamaguchi, H., Sakaguchi, H., Yoshida, K., Yabe, M., Yabe, H., Okuno, Y., Muramatsu, H., Takahashi, Y., Yui, S., Shiraishi, Y., et al. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1861-6 · Cited by 22
Ashbridge, B., Orte, Á., Yeoman, J. A., Kirwan, M., Vulliamy, T., Dokal, I. S., Klenerman, D., & Balasubramanian, S. (2009) · Biochemistry · doi:10.1021/bi901373e · Cited by 22
Self-citationTelomerase in hematologic malignancies
Bruedigam, C., & Lane, S. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000252 · Cited by 20
Yanowsky, K., Barroso, A., Osório, A., Urioste, M., Benitez, J. J., & Martínez–Delgado, B. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2141-2 · Cited by 19
Carrillo, J., González, A., Manguán-García, C., Pintado‐Berninches, L., & Perona, R. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1112-3 · Cited by 19
Calado, R. T., Regal, J. A., Kajigaya, S., & Young, N. S. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02209.x · Cited by 19
Telomeres, Telomerase, Stress, and Aging
Lin, J., Epel, E. S., & Blackburn, E. H. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb002065 · Cited by 19
Rolles, B., Tometten, M., Meyer, R., Kirschner, M., Beier, F., & Brümmendorf, T. H. (2024) · Transfusion Medicine and Hemotherapy · doi:10.1159/000540109 · Cited by 18
Lin, P., Mobasher, M. E., Hakakian, Y., Kakarla, V., Naseem, A. F., Ziai, H., & Alawi, F. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1359-6 · Cited by 18
Telomerase regulation: A key to inhibition?
Gómez, D. L. M., Fariña, H. G., & Gomez, D. E. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2104 · Cited by 18
GRIM-1, a Novel Growth Suppressor, Inhibits rRNA Maturation by Suppressing Small Nucleolar RNAs
Nallar, S. C., Lin, L., Srivastava, V., Gade, P., Hofmann, E. R., Ahmed, H., Reddy, S. P., & Kalvakolanu, D. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024082 · Cited by 19
Chu, T. W., MacNeil, D., & Autexier, C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714782 · Cited by 19
Zhou, J., Liang, B., & Li, H. (2010) · Biochemistry · doi:10.1021/bi1006699 · Cited by 20
Assani, G., Xiong, Y., Zhou, F., & Zhou, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.26150 · Cited by 17
Phase-Separated Subcellular Compartmentation and Related Human Diseases
Zhang, L., Wang, S., Wang, W., Shi, J., Stovall, D. B., Li, D., & Sui, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105491 · Cited by 18
Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics
Melicher, D., Buzás, E. I., & Falus, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1991-2 · Cited by 17
Shao, Y., Feng, S., Huang, J., Huo, J., You, Y., & Zheng, Y. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0549-1 · Cited by 17
Telomere replication: poised but puzzling
Sampathi, S., & Chai, W. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01220.x · Cited by 15
Martins‐de‐Souza, D., Carvalho, P. C., Schmitt, A., Junqueira, M., Nogueira, F. C. S., Turck, C. W., & Domont, G. B. (2013) · Journal of Proteome Research · doi:10.1021/pr4009157 · Cited by 16
Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications
Liu, Y., Eldomery, M. K., Maciaszek, J. L., & Klco, J. M. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-111523-023420 · Cited by 17
Telomere and Its Role in Diseases
Wang, S., Madu, C. O., & Lu, Y. W. (2019) · Oncomedicine · doi:10.7150/oncm.28210 · Cited by 17
Wang, J. Q., Yang, M. D., Chen, X., Wang, Y., Chen, L. Z., Cheng, X., & Liu, X. H. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1466881 · Cited by 14
Nop10 Is a Conserved H/ACA snoRNP Molecular Adaptor
Reichow, S., & Varani, G. (2008) · Biochemistry · doi:10.1021/bi800418p · Cited by 22
Hereditary and Congenital Nail Disorders
Juhlin, L., & Baran, R. (2001) · Wiley eBooks · doi:10.1002/9780470694947.ch9 · Cited by 14
tRNA ADENOSINE DEAMINASE 3 is required for telomere maintenance in Arabidopsis thaliana
Bose, S., Suescún, A. V., Song, J., Castillo-González, C., Aklilu, B. B., Branham, E. M., Lynch, R., & Shippen, D. E. (2020) · Plant Cell Reports · doi:10.1007/s00299-020-02594-0 · Cited by 13
Fidalgo, F., Torrezan, G. T., de Sá, B. C. S., Barros, B. D. D. F., Moredo, L. F., Valieris, R., SOUZA, S. J. D., Neto, J. P. D., Krepischi, A. C. V., & Carraro, D. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262419 · Cited by 13
Ishii, K., & Young, N. S. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.07.002 · Cited by 13
Maliński, B., Vertemara, J., Faustini, E., Ladenvall, C., Norberg, A., Zhang, Y., von Castelmur, E., Baliakas, P., Tisi, R., Cammenga, J., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad114 · Cited by 12
Metadata
- Authors
- Walne, A. J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.-H., Aljurf, M., & Dokal, I.
- Affiliations
- Queen Mary University of London (GB)
- King Faisal Specialist Hospital & Research Centre (SA)
- Corresponding author
- Walne, Amanda J.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-16
- Volume
- 16
- Issue
- 13
- Pages
- 1619-1629
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2882227
- OpenAlex
- W2107042037
- Cited by
- 316
- References
- 45
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 12 · 2021: 9 · 2020: 21 · 2019: 7 · 2018: 19 · 2017: 9 · 2016: 13 · 2015: 21 · 2014: 19 · 2013: 22 · 2012: 16
- FWCI
- 19.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (069399)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- dyskeratosis congenita, NOP10, telomerase, telomere maintenance, telomere shortening, consanguinity, homozygosity mapping, genetic heterogeneity, siRNA knockdown
- MeSH terms
- Adolescent, Adult, Amino Acid Sequence, Consanguinity, Genetic Markers, HeLa Cells, Homozygote, Humans, Genetic Linkage, Molecular Sequence Data, Mutation, Pedigree, Telomere, Telomerase, Dyskeratosis Congenita, Ribonucleoproteins, Small Nucleolar, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review